Nitroglycerin Controlled Release Tablets 6.4 Mg – TROMIST 6.4 Tablets

Composition  – Nitrogylcerin Controlled Release 6.4 mg

Description:
TROMIST 6.4 contains Nitroglycerin Controlled Release Tablets 6.4 mg, a vasodilator indicated for the prevention and long-term management of angina pectoris. The controlled-release formulation provides sustained delivery of Nitroglycerin, helping improve coronary blood flow, reduce cardiac workload, and provide prolonged protection against anginal episodes.

Key Points:

• Provides Sustained Anti-Anginal Protection – Controlled-release technology ensures prolonged therapeutic action for effective prevention of angina attacks.
• Improves Coronary Blood Flow – Dilates coronary blood vessels, enhancing oxygen supply to the heart muscle.
• Reduces Cardiac Workload – Decreases myocardial oxygen demand, helping the heart function more efficiently.
• Supports Long-Term Symptom Control – Helps reduce the frequency and severity of anginal episodes during daily activities.
• Convenient Once-Daily Therapy – Controlled-release formulation promotes better compliance with sustained cardiovascular support.

Targeted Specialties:
Cardiology
Internal Medicine
General Medicine
Emergency Medicine

Disclaimer:
To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.